In silico predictions of drug solubility and permeability:: Two rate-limiting barriers to oral drug absorption

被引:47
|
作者
Bergström, CAS [1 ]
机构
[1] Uppsala Univ, BMC, Dept Pharm, Ctr Pharmaceut Informat, SE-75123 Uppsala, Sweden
关键词
D O I
10.1111/j.1742-7843.2005.pto960303.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aqueous drug solubility and intestinal drug permeability are two of the most important factors influencing drug absorption. If the developability of a drug is to be included in the lead optimization, new experimental and computational models of solubility and permeability are needed. These models must have the capacity to handle a large amount of data. Nowadays, epithelial cell culture models such as Caco-2 are routinely used to assess intestinal drug permeability and transport in drug discovery settings. The permeability values obtained from the Caco-2 cell monolayers have been traditionally used to devise in silico models for the prediction of drug absorption. In this paper, the use of molecular surface areas as descriptors of permeability and solubility will be reviewed. Moreover, a virtual filter for the prediction of oral drug developability based on the successful combination of in vitro and in silico models of drug permeability and aqueous drug solubility will be discussed.
引用
收藏
页码:156 / 161
页数:6
相关论文
共 50 条
  • [41] Distinguishing between the Permeability Relationships with Absorption and Metabolism To Improve BCS and BDDCS Predictions in Early Drug Discovery
    Larregieu, Caroline A.
    Benet, Leslie Z.
    [J]. MOLECULAR PHARMACEUTICS, 2014, 11 (04) : 1335 - 1344
  • [42] RATE-LIMITING STEPS IN DRUG-METABOLISM BY MICROSOMES FROM CCL4-CIRRHOTIC RAT-LIVER
    TSYRLOV, IB
    LYAKHOVICH, VV
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 1975, 10 (02) : 77 - 89
  • [43] Rate-limiting steps in hepatic drug clearance: Comparison of hepatocellular uptake and metabolism with microsomal metabolism of saquinavir, nelfinavir, and ritonavir
    Parker, Alison J.
    Houston, J. Brian
    [J]. DRUG METABOLISM AND DISPOSITION, 2008, 36 (07) : 1375 - 1384
  • [44] Stabilizing p-Dithiobenzyl Urethane Linkers without Rate-Limiting Self-Immolation for Traceless Drug Release
    Zheng, Yiwu
    Shen, Yang
    Meng, Xiaoting
    Wu, Yaqi
    Zhao, Yibing
    Wu, Chuanliu
    [J]. CHEMMEDCHEM, 2019, 14 (12) : 1196 - 1203
  • [45] Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions
    Nicolas, Jean-Marie
    Bouzom, Francois
    Hugues, Chanteux
    Ungell, Anna-Lena
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 2017, 38 (03) : 209 - 230
  • [46] Extent and rate of oral drug absorption in minipigs: Comparison with mice, rats and humans
    Yoshimatsu, Hiromichi
    Ishii, Kunikazu
    Yamashita, Shinji
    [J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2020, 58
  • [47] STABLE METHOD FOR CALCULATING ORAL DRUG ABSORPTION RATE CONSTANTS WITH 2 COMPARTMENT DISPOSITION
    SAUNDERS, L
    NATUNEN, T
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 : P44 - P51
  • [48] Simultaneous Evaluation of Dissolution and Permeation of Oral Drug Solid Formulations for Predicting Absorption Rate–Limiting Factors and In Vitro–In Vivo Correlations: Case Study Using a Poorly Soluble Weakly Basic Drug
    Ziqiang Li
    Xin He
    Shuang Tian
    Guo Feng
    Cong Huang
    Mingjin Xun
    Zengguang Wu
    Yangyang Wang
    [J]. AAPS PharmSciTech, 20
  • [49] PREDICTING EFFECT OF SOLUBILIZERS ON THE ORAL ABSORPTION OF A LOW-SOLUBLE DRUG BY USING RAT SIMULATED GASTROINTESTINAL FLUIDS: THE IMPORTANCE OF REGIONAL DIFFERENCES IN MEMBRANE PERMEABILITY AND SOLUBILITY
    Tanaka, Yusuke
    Baba, Toshiyuki
    Nagata, Shunji
    [J]. DRUG METABOLISM REVIEWS, 2015, 47 : 47 - 47
  • [50] Hepatobiliary disposition of valproic acid and valproate glucuronide: Use of a pharmacokinetic model to examine the rate-limiting steps and potential sites of drug interactions
    Booth, CL
    Pollack, GM
    Brouwer, KLR
    [J]. HEPATOLOGY, 1996, 23 (04) : 771 - 780